CDC advisers will meet today about the J&J Covid-19 vaccine. Here’s what experts and state leaders say about the pause
By Christina Maxouris Advisers to the Centers for Disease Control and Prevention will meet Wednesday to review blood clot cases among people who received the Johnson & Johnson Covid-19 vaccine. The CDC and the US Food and Drug Administration a day earlier recommended the US pause the use of the single-shot J&J vaccine after “six reported US cases of a rare and severe type of blood clot.” The six cases were among more than 6.8 million Americans who have received a dose of that vaccine. “Less than 1 in a million,” Dr. Anthony Fauci noted Tuesday during a White House